Tag: Aurobindo Pharma

IndustryLatest Stories

AstraZeneca India to sell 64-acre Bengaluru site for ₹3,400 Cr

Representative AI image BENGALURU: AstraZeneca’s Indian arm plans to sell its 64-acre manufacturing facility in North Bengaluru as part of a review of its global supply and manufacturing network by its UK-based parent company. The land, estimated to garner around ₹3,400 crore for AstraZeneca Pharma India, has attracted interest from developers such as Sattva Group, Aurobindo Pharma, and RMZ. This sale is part of a broader land monetization initiative. A source indicated, “AstraZeneca has shortlisted three potential bidders and plans to finalize the deal soon.” The land, located in a prime area of North Bengaluru, is valued at over ₹53…

IndustryLatest Stories

Auro Realty Seeks $225M Bond in India for Acquisition Fund

MUMBAI: Auro Realty, the real estate division of Aurobindo Group, which also includes pharmaceutical producer Aurobindo Pharma, aims to raise ₹20 billion (approximately $225.41 million) via bond sales to finance a significant acquisition, according to two merchant bankers on Tuesday. The company plans to issue two-year and four-year bonds with coupon rates between 11% and 15%, the bankers noted. “This financing at the promoter level is intended for the acquisition of several assets, including Hotel Taj Banjara Hyderabad,” commented one of the bankers. The Auro Realty group has not responded to a Reuters email for further information, and the bankers,…